SinoMab
3681.HKSinoMab BioScience Limited Price (3681.HK)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
1,018,115,585
(2.6372)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
SinoMab BioScience LimitedCurrency: HKD
| YEAR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
0.00
+0% |
1,480,000.00
+0% |
0.00
+0% |
12,760,000.00
+0% |
26,657,000.00
+109% |
4,032,000.00
-85% |
1,365,000.00
-66% |
||||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 117,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 943,000.00 | ||||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
-117,000.00
+0% |
1,480,000.00
-1,365% |
0.00
+0% |
12,760,000.00
+0% |
26,657,000.00
+109% |
4,032,000.00
-85% |
422,000.00
-90% |
||||||||||||
| Gross Profit Ratio | (0.00%) | (1.00%) | (0.00%) | (1.00%) | (1.00%) | (1.00%) | (0.31%) | ||||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 32,603,000.00 | 47,283,000.00 | 214,342,000.00 | 103,402,000.00 | 199,113,000.00 | 180,368,000.00 | 135,409,000.00 | ||||||||||||
| General and Administrative | 991,000.00 | 2,014,000.00 | 61,544,000.00 | 71,085,000.00 | 131,935,000.00 | 82,427,000.00 | 97,441,000.00 | ||||||||||||
| Selling, General & Admin... | 991,000.00 | 2,014,000.00 | 61,544,000.00 | 72,010,000.00 | 133,400,000.00 | 82,591,000.00 | 97,615,000.00 | ||||||||||||
| Selling & Marketing Exp... | 0.00 | 0.00 | 0.00 | 925,000.00 | 1,465,000.00 | 164,000.00 | 174,000.00 | ||||||||||||
| Depreciation and Amortiz... | 1,103,000.00 | 1,075,000.00 | 2,236,000.00 | 4,042,000.00 | 20,655,000.00 | 14,634,000.00 | 36,064,000.00 | ||||||||||||
| Other Expenses | -16,000.00 | -617,000.00 | -77,000.00 | 0.00 | -180,000.00 | 0.00 | 0.00 | ||||||||||||
| Total Operating Expenses | 39,595,000.00 | 54,799,000.00 | 275,886,000.00 | 150,290,000.00 | 325,761,000.00 | 292,810,000.00 | 422,000.00 | ||||||||||||
| Cost and Exponses | 39,595,000.00 | 54,799,000.00 | 275,886,000.00 | 150,290,000.00 | 325,761,000.00 | 292,810,000.00 | 233,967,000.00 | ||||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
-39,595,000.00
+0% |
-54,799,000.00
+38% |
-273,944,000.00
+400% |
-162,652,000.00
-41% |
-305,856,000.00
+88% |
-258,927,000.00
-15% |
-229,575,000.00
-11% |
||||||||||||
| Operating Income Ratio | (0.00%) | (-37.03%) | (0.00%) | (-12.75%) | (-11.47%) | (-64.22%) | (-168.19%) | ||||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 39,000.00 | 116,000.00 | 2,993,000.00 | 14,930,000.00 | 10,910,000.00 | 4,620,000.00 | 6,176,000.00 | ||||||||||||
| Interest Expenses | 2,961,000.00 | 3,030,000.00 | 2,338,000.00 | 0.00 | 5,821,000.00 | 0.00 | 6,584,000.00 | ||||||||||||
| Total Other Income/Exp... | -12,306,000.00 | -28,811,000.00 | -396,000.00 | 40,052,000.00 | 17,662,000.00 | -25,231,000.00 | -13,536,000.00 | ||||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | -38,492,000.00 | -80,449,000.00 | -273,650,000.00 | -158,610,000.00 | -296,429,000.00 | -244,293,000.00 | -200,463,000.00 | ||||||||||||
| EBITDA ratio | (0.00%) | (-54.36%) | (0.00%) | (-12.43%) | (-11.12%) | (-60.59%) | (-146.86%) | ||||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | -51,901,000.00 | -83,610,000.00 | -276,282,000.00 | -122,600,000.00 | -288,194,000.00 | -284,158,000.00 | -243,111,000.00 | ||||||||||||
| Income Before Tax Ratio | (0.00%) | (-56.49%) | (0.00%) | (-9.61%) | (-10.81%) | (-70.48%) | (-178.10%) | ||||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | -13,272,000.00 | -25,781,000.00 | 2,338,000.00 | 0.00 | 9,190,442.00 | 0.00 | 0.00 | ||||||||||||
| Net Income | |||||||||||||||||||
| Net Income | -47,974,000.00
+0% |
-83,610,000.00
+74% |
-278,620,000.00
+233% |
-122,600,000.00
-56% |
-288,194,000.00
+135% |
-284,158,000.00
-1% |
-243,111,000.00
-14% |
||||||||||||
| Net Income Ratio | (0.00%) | (-56.49%) | (0.00%) | (-9.61%) | (-10.81%) | (-70.48%) | (-178.10%) | ||||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | -0.05 | -0.08 | -0.33 | -0.12 | -0.29 | -0.29 | -0.24 | ||||||||||||
| Diluted EPS | -0.05 | -0.08 | -0.33 | -0.12 | -0.29 | -0.29 | -0.24 | ||||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 1,006,240,400.00 | 1,006,240,400.00 | 836,654,781.00 | 1,006,245,947.00 | 994,887,333.00 | 991,957,048.00 | 1,018,116,715.00 | ||||||||||||
| Diluted Share Outstanding | 1,006,240,400.00 | 1,006,240,400.00 | 836,654,781.00 | 1,006,240,400.00 | 994,887,333.00 | 991,956,078.00 | 1,018,115,585.00 | ||||||||||||